| Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria RA Brodsky, NS Young, E Antonioli, AM Risitano, H Schrezenmeier, ... Blood, The Journal of the American Society of Hematology 111 (4), 1840-1847, 2008 | 727 | 2008 |
| Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study AG Kulasekararaj, A Hill, ST Rottinghaus, S Langemeijer, R Wells, ... Blood, The Journal of the American Society of Hematology 133 (6), 540-549, 2019 | 336 | 2019 |
| MicroRNA expression profiling in classic Hodgkin lymphoma A Navarro, A Gaya, A Martinez, A Urbano-Ispizua, A Pons, O Balagué, ... Blood, The Journal of the American Society of Hematology 111 (5), 2825-2832, 2008 | 234 | 2008 |
| Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma A Navarro, T Diaz, A Martinez, A Gaya, A Pons, B Gel, C Codony, G Ferrer, ... Blood, The Journal of the American Society of Hematology 114 (14), 2945-2951, 2009 | 216 | 2009 |
| Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients A Martínez-Trillos, A Gaya, M Maffioli, E Arellano-Rodrigo, X Calvo, ... Annals of hematology 89, 1233-1237, 2010 | 213 | 2010 |
| The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab R Kelly, L Arnold, S Richards, A Hill, C Bomken, J Hanley, A Loughney, ... British journal of haematology 149 (3), 446-450, 2010 | 177 | 2010 |
| Hematopoiesis-related microRNA expression in myelodysplastic syndromes A Pons, B Nomdedeu, A Navarro, A Gaya, B Gel, T Diaz, S Valera, ... Leukemia & lymphoma 50 (11), 1854-1859, 2009 | 121 | 2009 |
| Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation M Granell, A Urbano-Ispizua, B Suarez, M Rovira, F Fernández-Avilés, ... Experimental hematology 34 (10), 1435-1441, 2006 | 119 | 2006 |
| Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy J Rovira, A Valera, L Colomo, X Setoain, S Rodríguez, A Martínez-Trillos, ... Annals of hematology 94, 803-812, 2015 | 104 | 2015 |
| Lestaurtinib inhibition of the Jak/STAT signaling pathway in Hodgkin lymphoma inhibits proliferation and induces apoptosis T Diaz, A Navarro, G Ferrer, B Gel, A Gaya, R Artells, B Bellosillo, ... PloS one 6 (4), e18856, 2011 | 92 | 2011 |
| Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation M Granell, A Urbano-Ispizua, JI Aróstegui, F Fernández-Avilés, ... Haematologica 91 (10), 1372-1376, 2006 | 89 | 2006 |
| Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies F Fernández-Avilés, E Carreras, A Urbano-Ispizua, M Rovira, C Martínez, ... Journal of clinical oncology 24 (30), 4855-4861, 2006 | 83 | 2006 |
| Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia M Maffioli, M Camós, A Gaya, JC Hernández-Boluda, A Álvarez-Larrán, ... Leukemia research 35 (8), 1014-1019, 2011 | 68 | 2011 |
| Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation M Jiménez, C Martínez, G Ercilla, E Carreras, Á Urbano-Ispízua, ... Experimental hematology 33 (10), 1240-1248, 2005 | 62 | 2005 |
| Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation M Granell, A Urbano-Ispizua, A Pons, JI Aróstegui, B Gel, A Navarro, ... Blood, The Journal of the American Society of Hematology 112 (10), 4337-4342, 2008 | 53 | 2008 |
| PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma A Cordeiro, A Navarro, A Gaya, M Díaz-Beyá, B Gonzalez-Farré, ... Oncotarget 7 (29), 46002, 2016 | 43 | 2016 |
| A subcutaneously administered investigational RNAi therapeutic (ALN-CC5) targeting complement C5 for treatment of PNH and complement-mediated diseases: preliminary phase 1/2 … A Hill, A Gaya, M Griffin, T Munir, A Borodovsky, N Kawahata, H Mclean, ... Blood 128 (22), 3891-3891, 2016 | 34 | 2016 |
| MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients A Navarro, C Munoz, A Gaya, M Díaz-Beyá, B Gel, R Tejero, T Díaz, ... PloS one 8 (5), e64716, 2013 | 33 | 2013 |
| Anemia associated with impaired erythropoietin secretion after allogeneic stem cell transplantation: incidence, risk factors, and response to treatment A Gaya, A Urbano-Ispizua, F Fernández-Avilés, O Salamero, JM Roncero, ... Biology of Blood and Marrow Transplantation 14 (8), 880-887, 2008 | 32 | 2008 |
| Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double … JW Lee, M Griffin, JS Kim, LWL Lee, C Piatek, J Nishimura, CC Infante, ... The Lancet Haematology 10 (12), e955-e965, 2023 | 27 | 2023 |
Alfons NavarroFaculty of Medicine and Health Sciences, University of Barcelona在 ub.edu 的电子邮件经过验证
